PSO Case Law: Illinois Department of Financial and Professional Regulation (IDFPR) v. Walgreen, Company, 2012 IL App (2d) 110452, No. 2-11-0452 (May 29, 2012)
On May 29, 2012, an Illinois appellate court upheld a lower court’s decision that patient safety work product (PSWP) is privileged and not subject to discovery under the 2005 Patient Safety and Quality Improvement Act (PSQIA).
CASE OVERVIEW
The Illinois appeals court’s decision in favor of Walgreens is based on two provisions of the PSQIA¦
In making its decision, the appeals court determined that two affidavits prepared by Walgreens clearly satisfied the requirements of the PSQIA, resulting in protection for the subpoenaed documents.
The court cited the broad language of the PSQIA in protecting PSWP from discovery in connection with a federal, state, or local civil, criminal, or administrative proceeding. In so ruling, the court applied the broad federal protections provided under the PSQIA.
What Does This Mean for Health Care Providers?
The court ruling further reinforces the recommendations for PSO participants to ensure maximum protection:
A recent Pennsylvania case shows how courts narrowly interpret the PSQIA, ignoring the D & A pathway and the clear language of the Final Rule. (Ungurian v. Beyzman, et al., 2020 PA Super 105). The cour
The Center for Patient Safety wants to share this important harm-prevention advice from The Joint Commission and its Sentinel Event Alert: Managing the Risks of Direct Oral Anticoagulants. The Joint Commis
Issue: A number of events reported co CPS’ Patient Safety Organization (PSO) demonstrate poor handoff communication about the patients’ infectious disease status Examples include: Patient with
The Center for Patient Safety believes that collaboration and sharing are the best ways to drive improvement. We strive to provide the right solutions and resources to improve healthcare safety and quality.